Dolichol in the form of dolichyl phosphate participates in the synthesis of N-and O-linked glycoproteins and phosphatidylinositol-linked proteins in the yeast Saccharomyces cerevisiae. In this organism, as well as in higher eukaryotes, a number of the enzymes in the polyisoprenoid and glycoprotein biosynthetic pathways have not been identified. In this study, we have developed a convenient, highly sensitive assay that uses one of the end products of the dolichylphosphate synthetic pathway, oligosaccharide-diphosphodolichol, and a 12'I-labeled peptide substrate for N-linked glycosylation to screen a collection of temperature-sensitive yeast mutants for defects in protein glycosylation. By using a combination of biochemical and genetic procedures, the defective mutants were grouped into three categories: those containing defects in dolichyl-phosphate synthesis (class 1), lipid-linked oligosaccharide assembly (class 2), or oligosaccharide transferase activity (class 3). Among the mutants identified by this screen were secS9 (which encodes dolichol kinase) and a mutant that affects the activity of the ALGI-encoded mannosyltransferase that forms dolichol-PP-(GlcNAc)2Manj. Of particular interest was a mutant that exhibits a temperature-sensitive defect in oligosaccharide transferase activity. This mutant, meg) (microsomal protein essential for glycosylation 1) assembles a complete oligosaccharide chain and, therefore, is likely to be a class 3 mutant. We report the cloning ofMEGI, the gene that rescues the oligosaccharide transferase activity defect in this mutant. A number of criteria distinguish this gene from previously described genes in this pathway.
Since the discovery of the involvement of the long chain polyprenyl phosphate, dolichyl phosphate, in the pathway of assembly of the oligosaccharide chain of N-linked glycoproteins (for reviews, see refs. 1 and 2), a great deal of progress has been made in understanding the individual steps of this complex process. As shown in Fig. 1 , the overall pathway can be considered to occur in three phases. A number ofthe early steps in the first phase, the synthesis of dolichyl phosphate, have been elucidated. However, the details of the late steps in formation of this lipid, as well as the regulation of its synthesis, are not well understood. The second phase is the multistep, lipid-linked oligosaccharide assembly process, whereby dolichyl phosphate serves as an anchor for the assembly of oligosaccharide-disphosphodolichol. As shown, numerous steps in this phase have been delineated in yeast as the result of the availability of alg mutants (asparagine-linked glycosylation mutants; ref. 3) , although, here too, the details of some steps and the topology of the enzymes and products are unclear. Characterization of the enzyme involved in the final step, in which the oligosaccharide chain is transferred from the lipid anchor to -Asn-Xaa-Ser/Thr-sites in proteins has, for a number of year, eluded investigators. This step, catalyzed by oligosaccharide transferase (OT), has recently been characterized in part by Gilmore and coworkers (4, 5) , who reported that in canine pancreas microsomes OT consists of a three-component complex. Similarly, studies in yeast have provided evidence that OT in yeast contains at least two protein components (6, 7) .
As an outgrowth of earlier efforts to determine the specificity of OT we prepared a variety of labeled -Asn-Xaa-Ser/ Thr-peptides to determine their efficiency as substrates. The most effective substrate was found to be Asn-Lys(N6-pazidobenzoyl)-Thr-NH2 whose amino terminus was derivatized with 125I-labeled Bolton-Hunter reagent (bh) (8) . The availability of this peptide substrate enabled us to develop a simple, sensitive assay that could be used on small cultures oflysed yeast protoplasts. The objective was to identify yeast mutants that exhibited defects in one of the three phases of the dolichol-linked pathway: synthesis ofdolichyl phosphate, assembly of oligosaccharide-diphosphodolichol, or transfer of the complete oligosaccharide to the acceptor protein or peptide. As is evident in Fig. 1 , a defect leading to underproduction of any of the intermediates in phase 1 or 2 would result in impaired peptide glycosylation in phase 3.
In this study we report the results of the use of this assay as a screen for such yeast mutants and its application to a collection of temperature-sensitive (ts) mutants (9) . The validity of the screen is documented by the identification of known mutants in phases 1 and 2 of the overall assembly process (class 1 and class 2 mutants). In addition, evidence for the identification of a class 3 mutant that exhibits a ts defect in OT activity is reported. MEG], the gene that rescues the activity defect of this mutant, has been cloned. A number of criteria, including partial DNA sequence analysis, suggests that MEG) is an additional component of the OT complex.
EXPERIMENTAL PROCEDURES
Strains. The Saccharomyces cerevisiae ts collection of mutants isolated by Hartwell (9) (14) . All other reagents used were of the highest grade available from either Difco, Fisher Scientific, or Sigma.
Asn-Lys(N6-p-azidobenzoyl)-Thr-NH2 was a generous gift of S. Khan (Wistar Institute). The amino terminus was derivatized with 1251-labeled bh (monoiodo form, 2000Ci/ mmol; 1 Ci = 37 GBq; Amersham) as described (15), yielding 125I-bh-Asn-Lys(BzN3)-Thr-NH2, which was then purified by HPLC on a C18 reverse-phase column (Vydac) using a 0-60% acetonitrile gradient (16 The first step in characterization of these mutants was to determine if the reduction in peptide glycosylation was the result of a lesion in an endoplasmic reticulum associated protein rather than a mutation elsewhere in the cell. To do this, microsomes were prepared from each mutant, and equivalent amounts of microsomal protein were assayed for peptide glycosylation. The results of this assay, also shown in Table 1 , indicate that six of the seven mutants exhibited reduced levels of glycosylation activity at the level of microsomes. Microsomes from mutant 212 could not be prepared because this strain did not spheroplast under the conditions used in both the screen and in the microsome preparation. Thus, the apparent lack ofglycosylation activity in lysates of mutant 212 was probably a result of the failure to deliver the peptide substrate to the cell.
The second step in characterizing the remaining six mutants was to determine if the defect in peptide glycosylation activity was the result of a mutation in one gene and, if so, to determine if the mutation gave rise to the ts growth phenotype. Mutants were mated with wild-type (wt) strains (see Experimental Procedures) and sporulated, and the resulting tetrads were dissected (an average of six tetrads per mutant were examined). Segregants from each full tetrad were then assayed for peptide glycosylation activity and growth at 360C. The depressed level of peptide glycosylation from five of the six mutants (59, 148, 163, 265, and 283) was found to segregate 2:2 with respect to wt activity, showing that in these cases the peptide glycosylation defect was due to a single nuclear mutation. Additionally, the glycosylation defects in mutants 163 and 283 were found to cosegregate with the ts growth phenotype (data not shown).
Three Classes of Mutants Can Be Identified by This Screen. As shown in Fig. 1 and discussed in the Introduction, starting from the first step committed to dolichol synthesis (elongation of farnesyl-PP), a mutation detected by the screen measuring impairment of peptide glycosylation may fall into one of three classes corresponding to the three phases in the assembly process. Any mutation in the dolichol synthesis pathway (class 1) will lead to a decrease in the endogenous pool of lipid-linked oligosaccharide and, therefore, a decrease in peptide glycosylation. Similarly, mutations in enzymes involved in the assembly of the lipid-linked oligosaccharide (class 2), such as the asparagine-linked glycosylation, or aig mutants (3), will exhibit a decrease in peptide glycosylation. Parenthetically, only those class 2 mutants with alterations early in the oligosaccharide assembly pathway will be detected in this screen because ofthe specificity of the ConA-agarose beads. Finally, class 3 mutants are those that will exhibit impaired peptide glycosylation not because of a defect in the assembly of oligosaccharide-diphosphodolichol but as the result of an actual lesion in any of the components of OT.
Mutants 64 and 283 Are Class 1 Mutants. To distinguish mutants in the dolichol synthesis pathway (class 1) from all others, a biochemical complementation experiment was designed. In this experiment, dolichyl phosphate and UDPGlcNAc, GDP-Man, and UDP-Glc were incubated with microsomes prepared from each mutant. Any mutant having a defective enzyme in the dolichol synthesis pathway, and, therefore, a reduced pool of endogenous dolichyl phosphate to serve as a substrate in lipid-linked oligosaccharide assembly, will be rescued by the addition of exogenous dolichyl phosphate and the appropriate sugar nucleotides. The results in Table 2 Mutant 163 Is a Class 3 Mutant. In mutant 163, as mentioned above, the temperature sensitivity and glycosylation defect were found to cosegregate. The depressed peptide glycosylation activity in mutant 163 microsomes was not rescued by addition of exogenous dolichyl phosphate, and mutant 163 complemented the secS9 strain. Consequently mutant 163 is not a class 1 mutant. Moreover, mutant 163 complemented three of the known ts strains (algi, alg2, and alg4) defective in the lipid-linked oligosaccharide assembly pathway, indicating that it was not defective in any of these known steps in this process. To distinguish if mutant 163 was an additional class 2 mutant or a class 3 mutant, the lipidlinked oligosaccharide synthesized by mutant 163 was char- Fig. 2A) . Mutant 163 also synthesized the complete oligosaccharide at the same level as wt (Fig. 2B) , as well as shorter oligosaccharides. The analysis of the alg2 oligosaccharide shown in Fig. 2C Plasmids from transformants that grew at 360C were isolated, electroporated into E. coli, and reisolated from the bacteria. These plasmids were then digested with EcoRI and analyzed by agarose gel electrophoresis. Lane 1, 1-kb DNA ladder; lanes 2 and 3, pMEG1.1; lanes 4 and 5, pMEG1.2; lane 6, pMEG1.3. screened, 5 grew at 360C. Plasmids from these transformants were isolated and electroporated into E. coli, and the DNA isolated from the bacteria was digested with EcoRI. The digests were then analyzed by agarose gel electrophoresis. The results shown in Fig. 3 (6, 7) and OST48, ribophorin I, and ribophorin II in mammals (4, 5) ]. Furthermore, restriction analysis ofpMEGl revealed that the restriction pattern of pMEG1 was distinct from that of the ALG7, WBPI, or SWPI gene (data not shown). Additionally, transformation for mutant 163 (megl) with pSWP1, a multicopy suppressor of WBPI (7), did not rescue the temperature sensitivity of mutant 163 (data not shown).
In summary, we have designed a simple, yet highly sensitive assay to screen a ts collection of yeast strains for mutants defective in N-linked glycosylation. Initially, this screen was designed to identify components of OT. However, because this screen requires the presence of endogenous lipid-linked oligosaccharide, which is one of the two substrates for OT, it is clear that this screen can be used to identify defects in enzymes in the dolichol synthesis pathway, as well as lesions in assembly of oligosaccharyl-PPdolichol (See Fig. 1 ). Biochemical complementation experiments can quickly identify mutants as either possessing a defect prior to or after the point of dolichyl phosphate synthesis. More specifically, as shown in this study, addition of dolichyl phosphate and the three sugar nucleotides can overcome loss of glycosylation activity in microsomes as a result of a class 1 mutation. It will not, however, rescue class 2 or 3 mutants. Similarly, addition of exogenous oligosaccharyl-PP-dolichol with concomitant restoration of activity in microsomes would assign the mutant to be a class 1 or 2 mutant, whereas a failure to regain activity would point toward a defective class 3 mutation (i.e., OT). Alternatively, analysis of the oligosaccharide chain of the endogenous oligosaccharyl-PP-dolichol isolated from the mutant strain can distinguish between a defect in the oligosaccharide assembly pathway and a defective OT. These biochemical approaches, in conjunction with the use of yeast genetic techniques, should lead to the identification of the enzymes that catalyze steps in the pathway that are not well understood. These include (i) enzymes in the later steps in polyisoprenoid synthesis, whereby polyprenyl diphosphate is converted to dolichyl phosphate, (ii) enzymes in the assembly of oligosaccharyl-PP-dolichol as well as proteins that may be translocators or "flippases" of the lipid-linked oligosaccharide, and (iii) the enzyme that is the focus of our current efforts, OT.
With respect to OT, our finding provides further evidence that this enzyme in yeast is a multisubunit enzyme. Earlier work by Aebi and coworkers (6, 7) provided evidence that two proteins, Wbplp and Swplp, are components of this enzyme. Both proteins are essential for viability; yet, both are nonlimiting components of OT and are believed to be integral membrane proteins based on their deduced amino acid sequence. Using the screen described in this report, we have identified a ts mutant (163) in the Hartwell collection that is defective in peptide glycosylation. This defect is not a result of an alteration in the structure of the endogenous oligosaccharyl-PP-dolichol substrate, since analysis revealed that in the mutant the substrate is identical in size to the wt oligosaccharide. Genetic complementation studies, restriction mapping, and partial sequence analysis revealed that the mutation is not in a known gene in the oligosaccharyl-PPdolichol assembly pathway or in WBPJ or SWPI. Consequently it seems clear that this gene encodes a component of OT or a molecule that affects the activity of OT.
